These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 16207892)

  • 1. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research.
    Haroun N; Dunn L; Haroun A; Cadenhead KS
    Schizophr Bull; 2006 Jan; 32(1):166-78. PubMed ID: 16207892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample.
    Miller TJ; Zipursky RB; Perkins D; Addington J; Woods SW; Hawkins KA; Hoffman R; Preda A; Epstein I; Addington D; Lindborg S; Marquez E; Tohen M; Breier A; McGlashan TH
    Schizophr Res; 2003 May; 61(1):19-30. PubMed ID: 12648732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical implications for clinical practice and future research in "at risk" individuals.
    Singh F; Mirzakhanian H; Fusar-Poli P; de la Fuente-Sandoval C; Cadenhead KS
    Curr Pharm Des; 2012; 18(4):606-12. PubMed ID: 22239594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study Cohort.
    Cadenhead KS; Addington J; Cannon T; Cornblatt B; McGlashan T; Perkins D; Seidman L; Tsuang M; Walker E; Woods S; Heinssen R
    Early Interv Psychiatry; 2010 Aug; 4(3):220-6. PubMed ID: 20712727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group.
    Yung AR; Phillips LJ; Yuen HP; Francey SM; McFarlane CA; Hallgren M; McGorry PD
    Schizophr Res; 2003 Mar; 60(1):21-32. PubMed ID: 12505135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. At clinical high risk for psychosis: outcome for nonconverters.
    Addington J; Cornblatt BA; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Heinssen R
    Am J Psychiatry; 2011 Aug; 168(8):800-5. PubMed ID: 21498462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome.
    Correll CU; Penzner JB; Frederickson AM; Richter JJ; Auther AM; Smith CW; Kane JM; Cornblatt BA
    Schizophr Bull; 2007 May; 33(3):703-14. PubMed ID: 17478437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Are schizophrenic patients being told their diagnosis today in France?].
    Villani M; Kovess-Masféty V
    Encephale; 2017 Apr; 43(2):160-169. PubMed ID: 27372353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction and prevention of transition to psychosis in young people at incipient risk for schizophrenia.
    Phillips LJ; Yung AR; Yuen HP; Pantelis C; McGorry PD
    Am J Med Genet; 2002 Dec; 114(8):929-37. PubMed ID: 12457389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment implications of the schizophrenia prodrome.
    Kaur T; Cadenhead KS
    Curr Top Behav Neurosci; 2010; 4():97-121. PubMed ID: 21312398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatic and functional outcome in youth at ultra-high risk for psychosis: a longitudinal study.
    Lemos-Giráldez S; Vallina-Fernández O; Fernández-Iglesias P; Vallejo-Seco G; Fonseca-Pedrero E; Paíno-Piñeiro M; Sierra-Baigrie S; García-Pelayo P; Pedrejón-Molino C; Alonso-Bada S; Gutiérrez-Pérez A; Ortega-Ferrández JA
    Schizophr Res; 2009 Dec; 115(2-3):121-9. PubMed ID: 19786339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The schizophrenia prodrome revisited: a neurodevelopmental perspective.
    Cornblatt BA; Lencz T; Smith CW; Correll CU; Auther AM; Nakayama E
    Schizophr Bull; 2003; 29(4):633-51. PubMed ID: 14989404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory Impairments and Psychosis Prediction: A Scoping Review and Theoretical Overview.
    Seabury RD; Cannon TD
    Neuropsychol Rev; 2020 Dec; 30(4):521-545. PubMed ID: 33226539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-psychotic psychiatric disorder and subsequent risk of schizophrenia. Cohort study.
    Lewis G; David AS; Malmberg A; Allebeck P
    Br J Psychiatry; 2000 Nov; 177():416-20. PubMed ID: 11059994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Duration of untreated psychosis: A state-of-the-art review and critical analysis].
    Souaiby L; Gaillard R; Krebs MO
    Encephale; 2016 Aug; 42(4):361-6. PubMed ID: 27161262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of suicide and attempted suicide in Denmark. Epidemiological studies of suicide and intervention studies in selected risk groups.
    Nordentoft M
    Dan Med Bull; 2007 Nov; 54(4):306-69. PubMed ID: 18208680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathways to psychosis: a comparison of the pervasive developmental disorder subtype Multiple Complex Developmental Disorder and the "At Risk Mental State".
    Sprong M; Becker HE; Schothorst PF; Swaab H; Ziermans TB; Dingemans PM; Linszen D; van Engeland H
    Schizophr Res; 2008 Feb; 99(1-3):38-47. PubMed ID: 18055179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is there any point in detecting high risk factors prior to a first psychosis?].
    Klaassen MC; Nieman DH; Becker HE; Linszen DH
    Tijdschr Psychiatr; 2006; 48(6):467-76. PubMed ID: 16956006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.